Amgen (AMGN) Income from Continuing Operations (2009 - 2026)
Amgen's Income from Continuing Operations came in at $3.86 billion for Q3 2026, up 20.1% from $3.22 billion a year earlier and up 62.7% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Amgen reported Income from Continuing Operations of $9.39 billion, up 34.1% year-over-year; for FY2025, it was $7.71 billion, up 88.5% from FY2024.
- Income from Continuing Operations carries a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- Going back by year, Income from Continuing Operations was $4.09 billion in FY2024 (-39.1%), $6.72 billion in FY2023 (+2.5%), $6.55 billion in FY2022 (+11.2%) and $5.89 billion in FY2021 (-18.9%).
- The Q3 2026 figure represents the highest quarterly Income from Continuing Operations in data going back to Q1 2009.
- Year-over-year, Income from Continuing Operations has increased for six consecutive quarters, with growth averaging 41.6% over the last seven quarters.
- The fastest year-over-year change in Income from Continuing Operations over five years came in Q2 2022 (growth of 183.8%), and the weakest in Q4 2023 (a decline of 52.5%).
- Business Quant data shows AMGN's Income from Continuing Operations at $2.38 billion (Q2 2026), $1.82 billion (Q1 2026) and $1.33 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.86 Bn |
| Jun 30, 2026 | 2.38 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 3.22 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 627.00 Mn |
| Sep 30, 2024 | 2.83 Bn |
| Jun 30, 2024 | 746.00 Mn |
| Mar 31, 2024 | -113.00 Mn |
| Dec 31, 2023 | 767.00 Mn |
| Sep 30, 2023 | 1.73 Bn |
| Jun 30, 2023 | 1.38 Bn |
| Mar 31, 2023 | 2.84 Bn |
| Dec 31, 2022 | 1.62 Bn |
| Sep 30, 2022 | 2.14 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.90 Bn |
API Access
Amgen Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();